Latest Triptan Stories
Marketresearchreports.biz has added a new research report on the "Global Migraine Drugs Market 2015-2019" to its collection.
Targeting CGRP, Intranasal Capsaicin Shows Potential in Offering Rapid Pain Relief to Numerous Sufferers in Need of Additional Treatment Options NEW YORK, April 30, 2014 /PRNewswire/
Migraine sufferers have new hope for relief and a chance at a better quality of life thanks to the FDA-approved use of BOTOX® treatment for chronic migraines. Orlando,
Painful headaches that affect nearly a million people in the UK, and many more millions worldwide, may be partly caused by overuse of common painkillers such as aspirin, paracetamol and triptans...
Acupuncture and sham acupuncture appear equally effective in treating migraines.
MOUNTAIN VIEW, Calif., Aug. 2, 2011 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that its New Drug Application (NDA) for LEVADEXÂ® orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S.
An inexpensive, hundred-year-old therapy for pain â€“ aspirin â€“ is effective in high doses for the treatment of severe headache and migraine caused by drug withdrawal, according to a new study by researchers with the UCSF Headache Center.